Public Company News
Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023
HONG KONG, Dec. 15, 2023 /PRNewswire/ -- Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) and treatment-naïve acute myeloid le...
Ucommune Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING, Dec. 15, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), an office space manager and provider inChina, today announced that it received a notification letter (the "Notification Letter on Compliance") from the Listing Qualifications Department o...
ZKH Group Limited Announces Pricing of Initial Public Offering
SHANGHAI, Dec. 15, 2023 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform inChina, today announced the pricing of its initial public offering of 4,000,000 American depositary shares ("ADSs"), a...
Appotronics ALPD® cinema laser light source highlight CineAsia 2023
SHENZHEN, China, Dec. 15, 2023 /PRNewswire/ -- As the largest and most influential film and television equipment exhibition inAsia, CineAsia 2023 was held at the True Icon Hall inBangkok, Thailand from December 5 to 7, 2013. Appotronics Corporation Ltd., (Appotronics), the global leader in cinema...
Live from ASH 2023 | Oral Report Featuring Encouraging Data of Olverembatinib Combined with Reduced-Intensity Chemotherapy in Patients with Ph+ ALL Presented at the ASH Annual Meeting
SUZHOU, China and ROCKVILLE, Md., Dec. 14, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today thatProf. Xiaoyuan Gong of the Institute of Hemato...
Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC)
* Nona Biosciences will receive a total of up to $53 Million in upfront and near-term payments, with the potential for milestones of up to$1.05 billion plus royalties. * Pfizer partnership expands Nona's global network of collaborations, reinforcing its commitment to providing cutting-edge te...
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed
- Lunit's strategic global leap: to acquire all of Volpara shares at AUD 1.15 per share, envisioning completion by Q2 2024 SEOUL. South Korea, Dec. 14, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...
China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, Dec. 14, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that on December 13, 2023, t...
CLPS Incorporation Expands Overseas Credit Card Business with the Acquisition of Purple Potato Finance
HONG KONG, Dec. 14, 2023 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced that its wholly-owned subsidiary, Qinson Credit Card Services Limited ("QCC"), has successfully acquired 100% equity of Purple Potato Finance Limited ("Purple Potato"). This strat...
Fibocom Propels Digitalization of Smart Industry Terminals with Customized PCBA Solutions
The PCBA (Printed Circuit Board Assembly) is the core of electronic devices, combining industry know-how and the assembly of electronic components, which is a pivotal process for device manufacturers in the early stage of product design. By offering the customized PCBA solutions to smart terminal...
ZK International Group Co., Ltd. Celebrates Prestigious Recognition as a National "Little Giant Enterprise"
Company Chairman Emphasizes Commitment to Technological Innovation and Global Expansion WENZHOU, China, Dec. 14, 2023 /PRNewswire/ -- ZK International Group Co., Ltd. (Nasdaq: ZKIN) ("ZKIN", "ZK International" or the "Company"), a pioneer in innovation and technology, proudly announces its selec...
Joining Hands Towards a Shared Future----Signing Ceremony of Strategic Cooperation Between Ucommune and New World Development (Wuhan) Limited & Forum on Optimizing Building Economy and Collaborating for Breakthrough Development Successfully Held
BEIJING, Dec. 14, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), an office space manager and provider inChina, today announced that the signing ceremony of strategic cooperation between Ucommune and New World Development (Wuhan) Limited, the opening ce...
Yunji Announces Third Quarter 2023 Unaudited Financial Results
HANGZHOU, China, Dec. 14, 2023 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced its unaudited financial results for the third quarter ended September 30, 2023[1]. Third Quarter 2023 Highlights * Total rev...
Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs
SHANGHAI, Dec. 14, 2023 /PRNewswire/ -- The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced today that it will invest approximatelyUS$3.3 million (approximately 500 million yen[1]) in a global multicenter Phase III clinical trial project (the "Program") led by Fosun Ph...
Wondershare Virbo Unveils AI-Powered Video Translator: Bridging Language Divides with Innovation
VANCOUVER, BC, Dec. 14, 2023 /PRNewswire/ -- Wondershare Virbo, a leading AI avatar video creation platform, has recently unveiled a groundbreaking AI Video Translator feature. This innovative addition empowers users to swiftly translate their videos into multiple languages while seamlessly incor...
51Talk Online Education Group to Report Third Quarter 2023 Financial Results on Monday, December 18, 2023
Earnings Call Scheduled for 8:00 a.m. EST on December 18, 2023 SINGAPORE, Dec. 14, 2023 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSEAMERICAN: COE), a global online education platform with core expertise in English education, today announced that it will report...
COP28 Highlight: NaaS held "Enterprise-Association-Academy-Research" Hybrid Forum for Seeking Opportunity of China-UAE Cooperation in New Energy
DUBAI, UAE, Dec. 14, 2023 /PRNewswire/ -- On December 9, NaaS (NASDAQ: NAAS), the first U.S. listed EV charging service company inChina, in collaboration with China Association for NGO Cooperation and 21st Century Business Herald, held a top-level forum themed around "Opportunity and Practical Ex...
JinkoSolar awarded ESG Transparency Award from EUPD Research
MUNICH, Dec. 14, 2023 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it has been awarded with the ESG Transparency Award from EUPD Research. The ESG Tra...
NaaS Technology Listed in Solactive Electric Vehicle Charging Infrastructure Index
BEIJING, Dec. 13, 2023 /PRNewswire/ -- Lately, Solactive, a famous Germany -based innovation-driven index provider, announced to have included NaaS Technology (NASDAQ: NAAS), the first U.S. listed EV charging service company in China, into Solactive Electric Vehicle Charging Infrastructure Index si...
Abbisko Therapeutics Announces that U.S. FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021)
SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") today announced that its CSF-1R inhibitor pimicotinib (ABSK021) has been granted the fast track designation ("FTD") by the U.S. FDA for the treatment of tenosynovial giant cell tumor ("TGCT") patients ...
Week's Top Stories
Most Reposted
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 297 media titles]
2026-05-12 10:15Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 295 media titles]
2026-05-11 16:20Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 292 media titles]
2026-05-12 10:00Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 285 media titles]
2026-05-12 14:00Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 284 media titles]
2026-05-15 17:00